Propanc Biopharma, Inc. SEC filings PPCB

Propanc Biopharma, Inc. has 438 filings in SEC EDGAR's recent list, going back to Jun 23, 2011. Its latest annual report, Form 10-K, was filed on Sep 25, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (listing notice). The company's fiscal year ends on June 30.

Propanc Biopharma, Inc. SEC filings
Form Description Filed Period
S-1 Registration statement Oct 5, 2026 —
S-1 Registration statement Jul 17, 2026 —
S-1 Registration statement Apr 10, 2026 —
424B3 Prospectus Mar 6, 2026 —
S-1/A Amended registration statement Feb 19, 2026 —
S-1 Registration statement Feb 2, 2026 —
424B3 Prospectus Jan 30, 2026 —
S-1 Registration statement Dec 30, 2025 —
424B3 Prospectus Aug 18, 2025 —
424B4 Prospectus Aug 18, 2025 —
S-1/A Amended registration statement Jul 28, 2025 —
S-1/A Amended registration statement May 30, 2025 —
S-1/A Amended registration statement Apr 25, 2025 —
S-1/A Amended registration statement Apr 8, 2025 —
S-1/A Amended registration statement Apr 2, 2025 —
S-1/A Amended registration statement Mar 31, 2025 —
S-1 Registration statement Oct 30, 2024 —
424B4 Prospectus Oct 17, 2023 —
S-1/A Amended registration statement Oct 10, 2023 —
S-1/A Amended registration statement Oct 6, 2023 —
S-1 Registration statement Aug 11, 2023 —
424B3 Prospectus Apr 4, 2023 —
POS AM Filing Mar 24, 2023 —
424B3 Prospectus Feb 22, 2022 —
S-1/A Amended registration statement Feb 10, 2022 —
S-1 Registration statement Feb 3, 2022 —
POS AM Filing Jan 10, 2022 —
S-1/A Amended registration statement Nov 3, 2020 —
S-1/A Amended registration statement Oct 14, 2020 —
S-1/A Amended registration statement Aug 13, 2020 —
S-1/A Amended registration statement Jul 17, 2020 —
S-1/A Amended registration statement Jun 26, 2020 —
S-1 Registration statement May 13, 2020 —
S-1/A Amended registration statement Jan 24, 2020 —
S-1 Registration statement Dec 12, 2019 —
S-1/A Amended registration statement Jun 14, 2019 —
S-1 Registration statement May 23, 2019 —
424B3 Prospectus Mar 7, 2019 —
S-1 Registration statement Feb 25, 2019 —
424B3 Prospectus Oct 30, 2018 —
S-1 Registration statement Oct 17, 2018 —
424B3 Prospectus Apr 26, 2017 —
424B3 Prospectus Feb 7, 2017 —
424B3 Prospectus Feb 7, 2017 —
424B3 Prospectus Jan 6, 2017 —
424B3 Prospectus Jan 6, 2017 —
424B3 Prospectus Dec 12, 2016 —
424B3 Prospectus Dec 12, 2016 —
424B3 Prospectus Nov 18, 2016 —
424B3 Prospectus Nov 18, 2016 —
POS AM Filing Oct 6, 2016 —
POS AM Filing Oct 6, 2016 —
424B3 Prospectus Sep 19, 2016 —
424B3 Prospectus Sep 19, 2016 —
424B3 Prospectus Aug 26, 2016 —
424B3 Prospectus Aug 26, 2016 —
S-1 Registration statement Aug 19, 2016 —
424B3 Prospectus Aug 4, 2016 —
424B3 Prospectus Aug 4, 2016 —
424B3 Prospectus Jul 6, 2016 —
424B3 Prospectus Jul 6, 2016 —
S-1/A Amended registration statement Apr 14, 2016 —
S-1 Registration statement Mar 25, 2016 —
S-1/A Amended registration statement Dec 10, 2015 —
S-1 Registration statement Nov 23, 2015 —
POS AM No. 3 Jan 7, 2013 —
POS AM No. 2 Dec 17, 2012 —
POS AM Amendment Mar 29, 2012 —
424B3 Prospectus Dec 16, 2011 —
S-1/A Amended registration statement Dec 8, 2011 —
S-1/A Amended registration statement Nov 14, 2011 —
S-1/A Amended registration statement Oct 27, 2011 —
S-1/A Amended registration statement Sep 30, 2011 —
S-1/A Amended registration statement Aug 18, 2011 —
S-1 Registration statement Jun 23, 2011 —

Showing 75 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PPCB (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Camberwell, Victoria, Australia
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1517681
Former names
Propanc Health Group Corp (until Apr 5, 2017)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.